Registro:

Referencias:

• Lesterhuis, W.J., de Vries, I.J.M., Adema, G.J., Punt, C.J.A., Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results (2004) Ann Oncol, 15 (4), pp. iv145-iv151
• Delamarre, L., Mellman, I., Harnessing dendritic cells for immunotherapy (2011) Semin Immunol, 23, pp. 2-11
• Timmerman, J., Levy, R., Dendritic cell vaccine for cancer immunotherapy (1999) Annu Rev Med, 50, pp. 507-529
• O' Neill, H.C., Wilson, H.L., Limitations with in vitro production of dendritic cells using cytokines (2004) J Leukoc Biol, 75, pp. 600-603
• Morelli, A.E., Zahorchak, A.F., Larregina, A.T., Colvin, B.L., Logar, A.J., Takayama, T., Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation (2001) Blood, 98 (5), pp. 1512-1523
• Reis e Sousa, C., Dendritic cells in a mature age (2006) Nature, 6, pp. 476-482
• Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzi, C., Falo, L.D., Bone marrow derived dendritic cells pulsed with syngeneic tumour peptides elicit protective and therapeutic antitumour immunity (1996) Nature Med, 1, pp. 1297-1302
• Hegmans, J.P., Hemmes, A., Aerts, J.G., Hoogsteden, H.C., Lambrecht, B.N., Immunotherapy of Murine Malignant Mesothelioma Using Tumor Lysate-pulsed Dendritic Cells (2005) Am J Respir Crit Care Med, 171, pp. 1168-1177
• Rossowska, J., Pajtasz-Piasecka, E., Szyda, A., Ziêtara, N., Duoe, D., Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response (2007) Folia Histochem Cytobiol, 45 (4), pp. 349-355
• Chen, Z., Moyana, T., Saxena, A., Warrington, R., Jia, Z., Xiang, J., Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells (2001) Int J Cancer, 93, pp. 539-548
• Goldszmid, R.S., Idoyaga, J., Bravo, A.I., Steinman, R., Mordoh, J., Wainstok, R., Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma (2003) J Immunol, 171, pp. 5940-5947
• Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T., Falo, L.D., Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity (1996) J Exp Med, 183, pp. 283-287
• Benencia, F., Sprague, L., McGinty, J., Pate, M., Muccioli, M., Dendritic cells, the tumor microenvironment and the challenges for an effective antitumor vaccination (2011) J Biomed Biotechnol, 2012, pp. 1-15
• Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., DeLeo, A.B., Clarke, M.R., Lotze, M.T., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines (1996) J Exp Med, 83, pp. 87-97
• Shimizu, K., Fields, R.C., Giedlin, M., Mule, J., Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines (1999) Proc Natl Acad Sci USA, 96, pp. 2268-2273
• Pilon-Tomas, S., Mackay, A., Vohra, N., Mulé, J.J., Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma (2010) J Immunol, 184, pp. 3442-3449
• Vulink, A., Radford, K.J., Melief, C., Hart, D.N., Dendritic cells in cancer immunotherapy (2008) Adv Cancer Res, 99, pp. 363-407
• Banerjee, D.K., Dhodapkar, M.V., Matayeva, E., Steinman, R.M., Dhodapkar, K.M., Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients (2006) Blood, 108 (8), pp. 2655-2661
• Von Euw, E.M., Barrio, M.M., Furman, D., Levy, E.M., Bianchini, M., Peguillet, I., Phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10-1082 promoter genotype as predictor of disease progression (2008) J Transl Med, 6 (6)
• Aarntzen, J.G., Figdor, C.G., Adema, G.J., Punt, C.J., De Vries, J.M., Dendritic cell vaccination and immune monitoring (2008) Cancer Immunol Immunother, 57 (10), pp. 1559-1568
• Palucka, A.K., Ueno, H., Fay, J., Banchereau, J., Dendritic cells: a critical player in cancer therapy? (2008) J Immunother, 31, pp. 793-805
• Kalantari, T., Kamali-Sarvestani, E., Ciric, B., Karimi, M.H., Kalantari, M., Faridar, A., Generation of immunogenic and tolerogenic clinical-grade dendritic cells (2011) Immunol Res, 51 (2-3), pp. 153-160
• Aptsiauri, N., Cabrera, T., Garcia-Lora, A., Garrido, F., Cancer immune escape: implications for immunotherapy (2012) Cancer Immunol Immunother, 121, pp. 123-1219
• Madorsky-Rowdo, F.P., Lacreu, M.L., Mordoh, J., Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities (2012) Frontiers in immunology, 3, p. 103
• Lesterhuis, W.J., de Vries, I.J., Adema, G.J., Punt, C.J., Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results (2004) Ann Oncol, 15 (4), pp. iv145-iv151
• Nakai, N., Hartmann, G., Kishimoto, S., Katoh, N., Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters (2010) Pigment Cell Melanoma Res, 23, pp. 607-619
• Iwashita, Y., Tahara, K., Goto, S., Sasaki, A., Kai, S., Seike, M., A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer (2003) Cancer Immunol Immunother, 52, pp. 155-161
• Sims, R.B., Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer (2012) Vaccine, 30 (29), pp. 4394-4397
• Culshaw, S., Millington, O.R., Brewer, J.M., McInnes, I.B., Murine neutrophils present class II restricted antigen (2008) Immunol Lett, 118, pp. 49-54
• Abi Abdallah, D.S., Egan, C.E., Butcher, B.A., Denkers, E.Y., Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation (2011) Int Immunol, 23 (5), pp. 317-326
• Beauvillain, C., Cunin, P., Doni, A., Scotet, M., Jaillon, S., Loiry, M.L., CCR7 is involved in the migration of neutrophils to lymph nodes (2010) Gen Virol, 91, pp. 2158-2166
• Mikhak, Z., Luster, A.D., The emergence of basophils as antigen-presenting cells in Th2 inflammatory responses (2009) J Mol Cell Biol, 1 (2), pp. 69-71
• Van Gisbergen, K.P., Sanchez-Hernandez, M., Geijtenbeek, T.B., Van Kooyk, Y., Neutrophils mediate immune modulation of dendritic cells through glycosylation dependent interactions between Mac-1 and DC-SIGN (2005) J Exp Med, 201 (8), pp. 1281-1292
• Kumar, V., Sharma, A., Neutrophils: cinderella of innate immune system (2010) Int Immunopharmacol, 10, pp. 1325-1334
• Terrin, E., Beaman, B.L., Interferon-C activation of polymorphonuclear neutrophil function (2004) Immunology, 112, pp. 2-12
• Perrigoue, J.G., Saenz, S.A., Siracusa, M.C., Allenspach, E.J., Taylor, B.C., Giacomin, P.R., Major histocompatibility complex class II-dependent basophil-CD4+ T cell interactions promote TH2 cytokine-dependent immunity (2009) Nat Immunol, 10 (7), pp. 697-705
• Lotfi, R., Lotze, T., Eosinophils induce DC maturation, regulating immunity (2008) J Leukoc Biol, 83, pp. 456-460
• Mac Keon, S., Gazzaniga, S., Mallerman, J., Bravo, A.I., Mordoh, J., Wainstok, R., Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue (2010) Vaccine, 28, pp. 8162-8168
• Romero, C.D., Varma, T.K., Hobbs, J.B., Reyes, A., Driver, B., Sherwood, E.R., The toll-like receptor 4 agonist monophosphoryl lipid A augments innate host resistance to systemic bacterial infection (2011) Infect Immun, 79 (9), pp. 3576-3587
• Boxio, R., Bossenmeyer, C., Steinckwich, N., Dournon, C., Nube, O., Mouse bone marrow contains large numbers of functionally competent neutrophils (2004) J Leukoc Biol, 75, pp. 604-611
• Kozo, Y., Yukio, S., Motoki, I., Haruo, N., Takashi, Y., Atsushi, K., Granulocyte macrophage-colony stimulating factor delays neutrophil apoptosis and primes its function through Ia-type phosphoinositide 3-kinase (2002) J Leukoc Biol, 72, pp. 1020-1026
• Costantini, C., Micheletti, A., Calzetti, F., Perbellini, O., Pizzolo, G., Cassatella, M.A., Neutrophil activation and survival are modulated by interaction with NK cells (2010) Int Immunol, 22 (10), pp. 827-838
• Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X., Trinchieri, G., The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor (2002) J. Exp Med, 195, pp. 953-958
• Maruyama, K., Ii, M., Cursiefen, C., Jackson, D.G., Keino, H., Tomita, M., Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages (2005) J Clin Invest, 115 (9), pp. 2363-2372
• Wu, L., Liu, Y.J., Development of dendritic-cell lineages (2007) Immunity, 26, pp. 741-750
• Miloud, T., Hammerling, G.J., Garbio, N., Review of murine dendritic cells: types, location, and development (2010) Methods Mol Biol, 595, pp. 21-42
• Hume, D.A., Macrophages as APC and the dendritic cell myth (2008) J Immunol, 181, pp. 5829-5835
• Steinman, R.M., Turley, S., Mellman, I., Inaba, K., The induction of tolerance by dendritic cells that have captured apoptotic cells (2000) J Exp Med, 191 (3), pp. 411-416
• Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S., Bhardwaj, N., Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells (2000) J Exp Med, 191 (3), pp. 7423-7433
• Bennouna, S., Bliss, S.K., Curiel, T.J., Denkers, E.Y., Microbial infection activation of dendritic cells during neutrophils instruct recruitment and cross-talk in the innate immune system (2003) J Immunol, 171, pp. 6052-6058
• Megiovanni, A.M., Sanchez, F., Robledo-Sarmiento, M., Morel, C., Gluckman, J.C., Boudaly, S., Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes (2006) J Leukoc Biol, 79, pp. 977-988
• Scapini, P., Lapinet-Vera, J.A., Gasperini, S., Calzetti, F., Bazzoni, F., Cassatella, M.A., The neutrophil as a cellular source of chemokines (2000) Immunol Rev, 177, pp. 195-203
• Van Gisbergen, K.P., Geijtenbeek, T.B., Van Kooyk, Y., Close encounters of neutrophils and DCs (2005) Trends Immunol, 26 (12), pp. 626-631
• Park, S.J., Burdick, M.D., Mehrad, B., Neutrophils mediate maturation and efflux of lung dendritic cells in response to Aspergillus fumigatus germ tubes (2012) Infect Immunol, 80 (5), pp. 1759-1765
• Ludwig, I.S., Geijtenbeek, T.B., Van Kooyk, Y., Two-way communication between neutrophils and dendritic cells (2006) Curr Opin Pharmacol, 6, pp. 408-413

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------